Efficacy of fosaprepitant combined with tropisetron plus dexamethasone in preventing nausea and emesis during fractionated radiotherapy with weekly cisplatin chemotherapy: interim analysis of a randomized, prospective, clinical trial using competing risk analysis
Xie Song(Shantou University), Chuangzhen Chen(Shantou University), Yizhou Zhan(Shantou University), Siyan Wang(Shantou University), Yanxuan Wu(Shantou University), Yudong Yan(Shantou University), Chengbing Zeng(Shantou University), Qingxin Cai(Shantou University), Renxian Xie(Shantou University), Ruihong Huang(Shantou University), Ruoheng Wang(Shantou University), Xiaoluan Lin(Shantou University), Kang Huang(Shantou University)
Cited by 0
Related Papers
A tumor suppressor protein encoded by circKEAP1 inhibits osteosarcoma cell stemness and metastasis by promoting vimentin proteasome degradation and activating anti-tumor immunity
|Journal of Experimental & Clinical Cancer Research|2024|29
Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
|Frontiers in Oncology|2024|14
Effectiveness and safety of pelareorep plus chemotherapy versus chemotherapy alone for advanced solid tumors: a meta-analysis
|Frontiers in Pharmacology|2023|10
Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer
|Frontiers in Immunology|2025|6